We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publication Details

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm
Pertuzumab with Perjeta

Pertuzumab with Perjeta (April 2019)

This booklet explains what pertuzumab is, when it’s given and its possible side effects. Pertuzumab is the generic (non-branded) name of the drug. Its current brand name is Perjeta®.

Author(s)
Breast Cancer Care
Place of publication
London
Publisher
Date of publication
April 2019
Pages
12pp
Edition
1st edition
Price
Free. Postage charged on large orders.
Order reference
Format
Booklet
Language
English
Flesch readability score
57.1
Download this resource
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm